Oragenics and Aragen Bioscience enter agreement to accelerate development of TerraCoV2, a SARS-CoV-2 (COVID 19) vaccine candidate
On May 19, 2020, Oragenics announced, that through its wholly-owned subsidiary, Noachis Terra, it has entered into an…
-
-
Innovation Pharma’s Brilacidin reduced viral titer of SARS-CoV-2 by 75 percent after 1 hour of preincubation in an in vitro study
On May 19, 2020, Innovation Pharma announced that its anti-SARS-CoV-2 (COVID-19) drug candidate, Brilacidin, in an in vitro…
-
Bio-Techne and Kantaro Biosciences announced partnership to develop and scale production of COVID-19 serology test
On May 19, 2020, Bio-Techne and the Mount Sinai Health System in New York, through its commercial affiliate…
-
Roche highly accurate antibody test for COVID-19 went live at more than 20 initial lab sites in the US
On May 19, 2020, Roche announced its Elecsys Anti-SARS-CoV-2 antibody test is live at more than 20 commercial…
-
New study from pandemic epicenter described severe COVID-19 response in children
On May 19, 2020, the Albert Einstein College of Medicine reported that while most children infected with the…
-
Phlow Corp was awarded $354 million BARDA contract to manufacture essential medicines in shortage
On May 19, 2020, Phlow, a U.S.-based, public benefit drug manufacturing corporation, received federal government funding of $354…
-
CytoDyn and the Mexican National Institutes of Health announced a collaborative study of leronlimab for treatment of severe/critical COVID-19 Population
On May 19, 2020, CytoDyn announced it will be coordinating with the National Institution of Health of Mexico…
-
Biotechnology | Diagnostics | Disease | Neurology | NIH | Therapeutics
Autism risk estimated at 3 to 5% for children whose parents have a sibling with autism
On May 18, 2020, the National Institutes of Health (NIH) reported that roughly 3 to 5% of children…
-
Long-acting injectable drug prevents HIV among men and transgender women
On May 18, 2020, an investigational long-acting form of the HIV drug cabotegravir injected once every 8 weeks…
-
Global study tested malaria drug to protect health workers from COVID-19
On May 18, 2020, with $9 million from the COVID-19 Therapeutics Accelerator, an international group of physicians and…
-
NantKwest announced FDA authorization of IND application for mesenchymal stem cell product for treatment of severe COVID-19 patients
On May 18, 2020, NantKwest, now part of ImmunityBio, announced it had received authorization from the U.S. Food…
-
Quidel’s Lyra Direct SARS-CoV-2 assay received Emergency Use Authorization and CE Mark for molecular detection of COVID-19
On May 18, 2020, Quidel announced it had received Emergency Use Authorization (EUA) for the Lyra Direct SARS-CoV-2…
-
FDA cleared IND application to enable phase II trial of ViralClear’s merimepodib to treat adult patients with advanced COVID-19 to proceed
On May 18, 2020, BioSig Technologies and its subsidiary, ViralClear Pharmaceuticals, announced the U.S. Food and Drug Administration…
-
Thermo Fisher Scientific support of COVID-19 response expanded with US Government contract for products used in sample collection
On May 18, 2020, Thermo Fisher Scientific announced it had received a contract from the U.S. government to…
-
Todos Medical announced first commercial sale of COVID-19 antibody tests
On May 18, 2020, Todos Medical announced its first commercial sale of COVID-19 tests. The sale was made…
-
Biotechnology | COVID-19 | Infectious Disease | NIH | USDA | Vaccine
Investigational ChAdOx1 nCoV-19 vaccine protects monkeys against COVID-19 pneumonia
On May 16, 2020, a single dose of ChAdOx1 nCoV-19, an investigational vaccine against SARS-CoV-2, has protected six…
-
Duke-NUS, GenScript and A*STAR launched first-in-the-world SARS-CoV-2 serology test
On May 15, 2020, Duke-NUS Medical School, GenScript Biotech, and the Diagnostics Development Hub at Singapore’s Agency for…
-
CIRM board approved clinical trials targeting COVID-19 and sickle cell disease
On May 15, 2020, the California Institute for Regenerative Medicine (CIRM) board approved new clinical trials for COVID-19…
-
Hologic granted FDA Emergency Use Authorization for its second molecular test for COVID-19
On May 15, 2020, Hologic announced it had received Emergency Use Authorization (EUA) from the U.S. Food and Drug…
-
Abbott provided update on ID NOW
On May 14, 2020, Abbott’s ID NOW announced that was further clarifying product information to provide better guidance…
-
Biotechnology | COVID-19 | HIV | Infectious Disease | NIH | Therapeutics
NIH began clinical trial of hydroxychloroquine and azithromycin to treat COVID-19
On May 14, 2020, the National Institute of Allergy and Infectious Diseases (NIAID) announced that a clinical trial…
-
The FDA informed public about possible accuracy concerns with Abbott ID NOW point-of-care test
On May 14, 2020, the U.S. Food and Drug Administration (FDA) alerted the public to early data that…
-
Abivax received ANSM and ethics committee clearance to test its development candidate ABX464 in 1,034 Covid-19 patients in randomized phase 2b/3 clinical trial
On May 14, 2020 Abivax announced it had received clearance from France’s National Agency for the Safety of…
-
Vyriad announced development of new antibody test to determine protective immunity from COVID-19
On May 14, 2020 Vyriad announced that it had completed the development of a serology test to measure…
-
The USDA announced the release of Three Joy peaches
On May 14, 2020, the U.S. Department of Agriculture (USDA) announced the Agricultural Research Service (ARS) had released…
-
Countries begin large-scale screening for SARS-CoV-2 in sewage
On May 14, 2020,The Scientist reported that scientists in Spain are expecting to begin regularly analyzing sewage for…
-
First detailed analysis of immune response to SARS-CoV-2 bodes well for COVID-19 vaccine development
On May 14, 2020, scientists at La Jolla Institute for Immunology (LJI) announced they had resolved the uncertainty…
-
ViralClear published F1000 research in vitro data demonstrating synergy between merimepodib and remdesivir against SARS-CoV-2
On May 14, 2020, BioSig Technologies announced that an article titled, “The IMPDH inhibitor merimepodib provided in combination…
-
ABX464 inhibits replication of SARS-CoV-2 (COVID-19) in reconstituted human respiratory epithelium model
On May 14, 2020 Abivax announced that ABX464 inhibited replication of SARS-CoV-2 in an in vitro reconstituted human…
-
Immunic received regulatory approval from German Health Authority BfArM to initiate phase 2 clinical trial in COVID-19 patients
On May 13, 2020, Immunic announced that it had received first regulatory approval from Germany’s BfArM (Bundesinstitut für…
